Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-05 09:20:14 - browse：72

Blockchain data -- health tech coverage from STAT — Adobe

This year has seen the Federal Trade Commission crack down on digital health companies’ irresponsible data use. Since February, it has charged four companies with improperly handling sensitive health information — starting with the first-ever enforcement of its long-stagnant Health Breach Notification Rule, against GoodRx.

Now, the FTC is arming itself for even more aggressive enforcement. In June, it proposed changes to the Health Breach Notification Rule that would clarify its ability to regulate digital health companies and their use of health data — filling in some of the gaps left by the patient privacy law HIPAA, which in many cases doesn’t cover the fast-growing world of online and app-based health and wellness services.

“The FTC is seeking to put developers of these kind of apps on notice that they, too, have responsibilities to protect health data,” said Angie Matney, counsel focused on data privacy at the law firm Reed Smith.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Ethical issues complicate the benefits of medical crowdfunding

WSS

What American doctors can learn from their Israeli counterparts

House panel takes first step toward fixing drug shortages

Transgender sports debate: Physicians say bans are health issue

Why Novartis is changing the name of its research labs

A rare thyroid diagnosis led to unexpected, all

NIH nominee Bertagnolli will get October confirmation hearing

Wikipedia

Wikipedia

Wikipedia

Bright Health sells Medicare Advantage business to Molina

The unintended consequences of overturning Roe v. Wade

Heart attack and stroke risk calculators need revising

A rare thyroid diagnosis led to unexpected, all

Hollywood unions extend contract negotiations for actors

Snackable artificial intelligence, expert AI, and the pharma industry

ChatGPT in medicine: STAT answers readers' burning questions

PBMs drew scrutiny in House hearing — and so did pharma

At least 13 dead in Texas as scorching temps continue

PBMs drew scrutiny in House hearing — and so did pharma

focus

Illumina names Agilent executive as new CEO

The 10 drugs up first for Medicare price negotiation

House panel takes first step toward fixing drug shortages

The (many) problems with a new study criticizing cancer screening

How generative AI is inspiring dreams of a health data revolution

Senate bill would ban some hospital facility fees

hotspot

explore

hotspot

leisure time